drugset
drugset / Trial / NCT00828724

Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State

NCT00828724 ↗

Phase 1 Completed 24 enrolled Eisai Inc.
CrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the PK properties in fed and fasted men and women.

Timeline

Start
2008-11
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorcaserin Small molecule 10 mg —

Indications

obesity disorder